Home / Resource Library / LONG TERM RESULTS OF A PHASE I/IB STUDY OF IBRUTINIB IN COMBINATION WITH UMBRALISIB IN PATIENTS WITH RELAPSED/REFRACTORY CLL OR MCL
LONG TERM RESULTS OF A PHASE I/IB STUDY OF IBRUTINIB IN COMBINATION WITH UMBRALISIB IN PATIENTS WITH RELAPSED/REFRACTORY CLL OR MCL